Wavefront abberations come in good, bad and ugly varieties

Article

While smooth wavefronts are to be preferred, some abberations may be beneficial and further study is need to identify them, said Jos Rozema, MD, of University Hospital Antwerp, Belgium.

While smooth wavefronts are to be preferred, some abberations may be beneficial and further study is need to identify them, said Jos Rozema, MD, of University Hospital Antwerp, Belgium.

Characterising wavefront varieties as the good, the bad and the 'downright' ugly, Dr Rozema noted that some higher order aberrations (HOAs) may improve vision. Studies by Schalhorn and McLellan in 2000 and 2002, respectively, revealed that US Navy pilots who require excellent vision often demonstrate HOAs, for example trefoil and Polychromiatic MTF (modulation transfer function) is usually better in mildly aberrated eyes.

Furthermore, eyes that are too corrected can suffer from reduced depth of focus, postoperative floaters and chromatic distortions after intraocular lens (IOL) implantation. "A good wavefront features regular myopia or hyperopia, or regular astigmatism, while emmetropia with minor HOAs is the ideal," said Dr Rozema. "There is an absence of lower order aberrations."

"Bad wavefronts contain a large amount of any aberration geometry and demonstrate steep wavefront slopes, making them difficult to correct by means of spectacles or contact lenses," he said.

Ugly wavefronts contain large amounts of 'micro aberrations' which are below the spatial resolution of aberrometers, and rough wavefronts are impossible to correct by conventional means. "This is usually an unintended surgical result," said Dr Rozema.

Ugly wavefronts are particularly challenging. Dr. Rozema referred one 29 year-old female patient who will need a corneal transplant to repair the damage caused by four LASIK procedures and an Intacts implantation.

Dr Rozema concluded that futher study is required to establish benchmarks identifying abberations and their impact on the quality of vision.

Ophthalmology Times Europe reporting from the XXIV Congress of the ESCRS, London, 9-13 September, 2006.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.